PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
The Korean Journal of Urological Oncology10.22465/kjuo.2021.19.1.60202119160-69Serum Testosterone Level as Possible Predictive Marker for Prognosis in Metastatic Castration-Resistant Prostate Cancer Patients Treated With EnzalutamideDong Hyeon An, Hwiwoo Kim, Donghyun Lee, In Gab Jeong, Dalsan You, Jun Hyuk Hong, Choung-Soo Kim, Hanjong Ahnhttp://kjuo.or.kr/upload/pdf/kjuo-19-1-60.pdf, http://kjuo.or.kr/journal/view.php?doi=10.22465/kjuo.2021.19.1.60, http://kjuo.or.kr/upload/pdf/kjuo-19-1-60.pdf
OncoTargets and Therapy10.2147/ott.s804882015871Enzalutamide for patients with metastatic castration-resistant prostate cancerWijdan Ramadan, Wissam Kabbara, Hiba Al Basiouni Al Masrihttps://www.dovepress.com/getfile.php?fileID=24682
Annals of Oncology10.1016/j.annonc.2020.10.452202031S1332232P Real-world data on metastatic castration-resistant prostate cancer patients treated with abiraterone or enzalutamide: A regional experienceR. Raju, A. Sahu, M. Klevansky, J. Torreshttps://api.elsevier.com/content/article/PII:S0923753420429436?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0923753420429436?httpAccept=text/plain
Managing Metastatic Prostate Cancer In Your Urological Oncology Practice10.1007/978-3-319-31341-2_102016157-169Enzalutamide in Metastatic Castration Resistant Prostate CancerJeffrey Shevach, Bridget K. Marcellino, William K. Oh, Che-Kai Tsaohttp://link.springer.com/content/pdf/10.1007/978-3-319-31341-2_10
Drugs10.1007/s40265-013-0129-9201373151723-1732Enzalutamide: A Review of Its Use in Metastatic, Castration-Resistant Prostate CancerMark Sanfordhttp://link.springer.com/content/pdf/10.1007/s40265-013-0129-9.pdf, http://link.springer.com/article/10.1007/s40265-013-0129-9/fulltext.html, http://link.springer.com/content/pdf/10.1007/s40265-013-0129-9
Cancer Treatment and Research Communications10.1016/j.ctarc.2020.100205202025100205Improvement in overall survival with Apalutamide, Darolutamide and Enzalutamide in patients with non-metastatic castration-resistant prostate cancerUmang Swami, Neeraj Agarwalhttps://api.elsevier.com/content/article/PII:S2468294220300423?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S2468294220300423?httpAccept=text/plain
Managing Metastatic Prostate Cancer In Your Urological Oncology Practice10.1007/978-3-319-31341-2_5201665-75Predictive Models in Castration Resistant Prostate CancerTao Cui, Michael W. Kattanhttp://link.springer.com/content/pdf/10.1007/978-3-319-31341-2_5
The Prostate10.1002/pros.239382019803247-255Higher serum testosterone levels predict poor prognosis in castrationā€resistant prostate cancer patients treated with docetaxelKeisuke Ando, Shinichi Sakamoto, Nobushige Takeshita, Ayumi Fujimoto, Maihulan Maimaiti, Shinpei Saito, Pae Sanjyon, Yusuke Imamura, Nobuo Sato, Akira Komiya, Koichiro Akakura, Tomohiko Ichikawahttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fpros.23938, https://onlinelibrary.wiley.com/doi/pdf/10.1002/pros.23938, https://onlinelibrary.wiley.com/doi/full-xml/10.1002/pros.23938, https://onlinelibrary.wiley.com/doi/pdf/10.1002/pros.23938
Prostate Cancer and Prostatic Diseases10.1038/s41391-020-0209-32020232220-231Revealing the prognostic landscape of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in metastatic castration-resistant prostate cancer patients treated with abiraterone or enzalutamide: a meta-analysisYupeng Guan, Haiyun Xiong, Yupeng Feng, Guolong Liao, Tongyu Tong, Jun Panghttp://www.nature.com/articles/s41391-020-0209-3.pdf, http://www.nature.com/articles/s41391-020-0209-3, http://www.nature.com/articles/s41391-020-0209-3.pdf
Prostate Cancer and Prostatic Diseases10.1038/s41391-021-00318-32021Survival outcomes in patients with chemotherapy-naive metastatic castration-resistant prostate cancer treated with enzalutamide or abiraterone acetateScott T. Tagawa, Krishnan Ramaswamy, Ahong Huang, Jack Mardekian, Neil M. Schultz, Li Wang, Rickard Sandin, Stanislav Lechpammer, Daniel J. Georgehttp://www.nature.com/articles/s41391-021-00318-3.pdf, http://www.nature.com/articles/s41391-021-00318-3, http://www.nature.com/articles/s41391-021-00318-3.pdf